Compare BIIB & GDDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIIB | GDDY |
|---|---|---|
| Founded | 1978 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 17.2B |
| IPO Year | 1991 | 2015 |
| Metric | BIIB | GDDY |
|---|---|---|
| Price | $175.33 | $125.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 13 |
| Target Price | $177.40 | ★ $187.00 |
| AVG Volume (30 Days) | ★ 2.3M | 1.4M |
| Earning Date | 02-11-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 10.97 | 5.80 |
| Revenue | ★ $10,065,900,000.00 | $4,869,800,000.00 |
| Revenue This Year | $3.58 | $10.25 |
| Revenue Next Year | N/A | $6.94 |
| P/E Ratio | ★ $16.07 | $21.74 |
| Revenue Growth | 4.77 | ★ 8.68 |
| 52 Week Low | $110.04 | $121.94 |
| 52 Week High | $185.17 | $216.00 |
| Indicator | BIIB | GDDY |
|---|---|---|
| Relative Strength Index (RSI) | 53.90 | 41.40 |
| Support Level | $175.00 | $125.81 |
| Resistance Level | $178.46 | $127.61 |
| Average True Range (ATR) | 3.87 | 1.94 |
| MACD | -0.58 | 0.11 |
| Stochastic Oscillator | 53.80 | 23.58 |
Biogen is an established biopharmaceutical company focused on treatments for neurological diseases and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 45% of total revenue in 2024. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (18% of total in 2024), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).
GoDaddy provides a comprehensive portfolio of solutions to help entrepreneurs manage their company's digital presence. In particular, GoDaddy helps customers establish websites, attract customers, and generate revenue. It operates through two segments—the core platform and applications and commerce. The core platform consists of domain registration services as well as hosting and security services. The newer applications and commerce segment consists of website design, marketing tools, and payment services. As of fiscal 2024, the company had over 20,000 customers and greater than 80 million domains under management.